Month: July 2025

Introduction and Objective: Few psychosocial interventions exist for families in the first year after a T1D diagnosis. Initial findings from the Triple T pilot, a telehealth intervention designed to support family coping during this first year are reported.Methods: Inclusion criteria: child with a new diagnosis of T1D and fluency in English. Families participated in 6 […]

Introduction and Objective: Habit theory describes context stability as important for the development of habit automaticity, but its role in insulin habit automaticity and adherence is unknown. The objective of the study was to examine the roles of context and context stability on insulin habit automaticity and adherence in adults with T1D.Methods: Adults with T1D […]

Introduction and Objective: Diabetic foot ulcer (DFUs) are a major cause of hospitalizations, yet post-discharge care coordination remains suboptimal. Effective care organization among specialists is crucial for limb salvage. Patient navigators are an effective model for chronic disease management, but their impact on DFU care is understudied. Here, we evaluated the use of certified diabetes […]

Introduction and Objective: Transition from pediatric to adult diabetes care is a complex process for YA with T1D. However, little is known about demographic and clinical characteristics of YA who return to pediatric care after initiating the transfer to adult care. We explored characteristics of YA who did or did not return to pediatric care […]

Introduction and Objective: Young adults with type 1 diabetes (T1D) are vulnerable when transitioning from pediatric to adult care. The Young Adult Diabetes Clinic (YADC) employs a multidisciplinary model to facilitate this transition through a single-session orientation led by a behavioral health specialist. We aim to understand the impact of the YADC, participant characteristics, and […]

Introduction and Objective: GCGR agonism stimulates energy expenditure (EE) and weight loss in rodents. Moreover, when combined with the antidiabetic actions of incretins (GLP1, GIP), GCGR-agonists lack hyperglycemic side effects. We also identified anti-obesity effects of GCGR agonism for 50d after treatment cessation. Thus, we hypothesized that a GLP-1/GIP/GCGR triple agonist (GGG) will increase EE […]

Introduction and Objective: Personality may influence key glycemic, behavioral, and emotional outcomes in people with T1D. We investigated Five-Factor Model (FFM) personality traits as predictors of self-management (SM), diabetes distress, and continuous glucose monitoring (CGM) metrics among 187 diverse adults with T1D.Methods: Participants wore CGM and rated their SM (each evening on a 0-100 scale) […]

Introduction and Objective: Insulin resistance (IR) and higher BMI are associated with the development of MASLD. However, their independent association with “at-risk” MASLD (i.e., steatohepatitis with clinically significant fibrosis or stage ≥F2; MASLD≥F2) is unclear. We investigated how IR and obesity interact to impact MASLD severity.Methods: We divided 283 individuals without diabetes into having overweight […]

Introduction and Objective: The growing prevalence of diabetes underscores the need for scalable, patient-centric tools to support diabetes self-management and education (DSME). Mitraa, a GPT-based conversational AI model, was developed to provide personalized diabetes care, including guidance on nutrition, medication adherence, glucose monitoring, and lifestyle adjustments. This study validates Mitraa’s effectiveness in delivering accurate, patient-relevant […]

Introduction and Objective: Type 2 diabetes (T2D) is often associated with metabolic dysfunction-associated steatotic liver disease (MASLD) which may lead to clinically significant fibrosis (defined as moderate-to-severe fibrosis stage ≥F2 or “at-risk” MASLD≥F2) and eventually cirrhosis. The role of insulin resistance (IR) in the development of MASLD≥F2 remains unclear. We examined the relationship of IR […]